• HEMANTH A Department of Pharmaceutics, Research Scholar JNTUA, Ananthapuramu, Andhra Pradesh, India.
  • HINDUSTAN ABDUL AHAD Department of Pharmaceutics, JNTUA-OTPRI, Ananthapuramu, Andhra Pradesh, India.
  • DEVANNA N Department of Pharmaceutics, JNTUA-OTPRI, Ananthapuramu, Andhra Pradesh, India.


Objective: The main objective of the current research is focused in discovering the best polyethylene glycol (PEG) as solid dispersion carrier using etoricoxib (ECB) as a model drug.

Methods: Varieties of PEG, namely PEG - 3350, PEG - 4000, PEG - 6000, PEG - 8000, and PEG - 20000, were evaluated as a carrier for making ECB solid dispersions. ECB:PEG was taken in the ratios of 1:1, 1:2, 1:4, and 1:6. The solid dispersions were prepared by microwave fusion method and compressed using 8 station tablet compression machine. The fabricated solid dispersion tablets were tested for physicochemical characteristics and drug release rates. The release of ECB from the prepared solid dispersions was further analyzed kinetically using the first order and Hixson-Crowell’s plots.

Results: All the solid dispersion batches were shown satisfactory physicochemical characteristics. ECB solid dispersion batches with PEG - 6000 showed good solubility in distilled water (up to 2.29±0.01 μg/ml) and in 0.1 N HCl (up to 2.18±0.01 μg/ml) when compared with ECB alone (0.21±0.01 μg/ml and 0.32±0.01 μg/ml). The prepared solid dispersions with PEG 6000 are shown good ECB release.

Conclusion: Among PEG carriers, PEG - 6000 was found to be the best carrier for increasing the solubility and release rate of ECB form the solid dispersions compared to PEG - 3350, PEG - 4000, PEG - 8000, and PEG - 20000.

Keywords: Etoricoxib, Polyethylene glycol, Solid dispersions, Evaluation.

Author Biography

HEMANTH A, Department of Pharmaceutics, Research Scholar JNTUA, Ananthapuramu, Andhra Pradesh, India.



1. Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971;60:1281-302.
2. Takemoto JK, Reynolds JK, Remsberg CM, Vega-Villa KR, Davies NM. Clinical pharmacokinetic and pharmacodynamic profile of etoricoxib. Clin Pharmacokinet 2008;47:703-20.
3. Agrawal NG, Porras AG, Matthews CZ, Rose MJ, Woolf EJ, Musser BJ, et al. Single-and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man. J Clin Pharmacol 2003;43:268-76.
4. Kahovec J, Fox RB, Hatada K. Nomenclature of regular single-strand organic polymers. Pure Appl Chem 2002;74:1921-56.
5. Chen SL, Cai SR, Deng L, Zhang XH, Luo TD, Peng JJ, et al. Efficacy and complications of polyethylene glycols for treatment of constipation in children: A meta-analysis. Medicine (Baltimore) 2014;93:e65.
6. Dannenfelser RM, He H, Joshi Y, Bateman S, Serajuddin AT. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. J Pharm Sci 2004;93:1165-75.
7. Wang X, Michoel A, Van den Mooter G. Study of the phase behavior of polyethylene glycol 6000-itraconazole solid dispersions using DSC. Int J Pharm 2004;272:181-7.
8. Law D, Schmitt EA, Marsh KC, Everitt EA, Wang W, Fort JJ, et al. Ritonavir-PEG 8000 amorphous solid dispersions: In vitro and in vivo evaluations. J Pharm Sci 2004;93:563-70.
9. Otsuka M, Onoe M, Matsuda Y. Hygroscopic stability and dissolution properties of spray-dried solid dispersions of furosemide with eudragit. J Pharm Sci 1993;82:32-8.
10. Poovi G, Rajpriyadarsini S, Uma S, Vinothini R. Development, characterization and solubility enhancement of comparative dissolution study of second generation of solid dispersions and microspheres for poorly water soluble drug. Asian J Pharm Sci 2015;10:433-41.
11. Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy. Philadelphia, PA: Lea and Febiger; 1987. p. 317-8.
12. Martin A. Physical Pharmacy. 4th ed. Maryland, USA: Lippincott Williams and Wilkins; 1991. p. 423.
13. Jachowicz R, Niirnberg E, Hoppe R. Solid dispersions of oxazepam. Int J Pharm 1993;99:321-5.
14. Sheu MT, Yeh CM, Sokoloski TD. Characterization and dissolution of fenofibrate solid dispersion systems. Int J Pharm 1994;103:137-46.
15. United State Pharmacopoeial Convention. The United State Pharmacopoeia 24, NF 19. Rockville, M.D: United State Pharmacopoeial Convention, Asian Edi.; 2000. p. 1462-5, 1913-4.
16. Shashi KY, Veena M, Srinivas M. Solid dispersion technique to enhance the solubility and dissolution rate of aripiprazole by fusion method. Int J Pharm Pharm Sci 2016;8:187-92.
17. Gamal MM, Samar FG. Preparation and evaluation of rapidly dissolving tablets of raloxifene hydrochloride by ternary system formation. Int J Pharm Pharm Sci 2016;8:127-36.
18. Hindustan AA, Chitta SK, Ravindra BV, Harika B. Fabrication and in vitro evaluation of gliclazide Abelmoschus esculentus fruit mucilage prolonged release matrix tablets. J Pharm Res 2011;4:118-20.
19. Dalmora SL, Sangoi Mda S, da Silva LM, Macedo RO, Barth T. Validation of a capillary zone electrophoresis method for the comparative determination of etoricoxib in pharmaceutical formulations. J Sep Sci 2008;31:169-76.
20. Singh S, Mishra A, Verma A, Ghosh AK, Mishra AK. A simple ultraviolet spectrophotometric method for the determination of etoricoxib in dosage formulations. J Adv Pharm Technol Res 2012;3:237-40.
21. Modi A, Tayade P. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS PharmSciTech 2006;7:68.
22. Korsmeyer RW, Gunny R, Doelker EM, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35.
23. Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-9.
24. Remunan C, Bretal M, Nunez A Bila JL. Accelerated stability of sustained release tablet prepared with gelucire. Int J Pharm 1992;80: 151-9.
168 Views | 449 Downloads
How to Cite
A, H., H. ABDUL AHAD, and D. N. “EVALUATING THE BEST POLYETHYLENE GLYCOL AS SOLID DISPERSION CARRIER BY TAKING ETORICOXIB AS A MODEL DRUG”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 12, no. 3, Mar. 2019, pp. 250-5, doi:10.22159/ajpcr.2019.v12i3.30251.
Original Article(s)